Tamoxifen Tablets

Formulated to alleviate estrogen-responsive tumour growth to support breast cancer remission and target cancer cells.

Dosage

Pack size

The exact manufacturer offered is confirmed by the fulfilment partner before supply.

Prescription and consultation requirements for Tamoxifen Tablets vary by destination and are determined by the fulfilment partner.

Tamoxifen Tablets details

Condition: Breast Cancer
Alternative names: nolvadex
Therapeutic class: Selective Estrogen Receptor Modulator (SERM)
Pharmacological class: Antineoplastic
Known off-label uses: ovulation induction
Contraindications: pregnancy; history of deep vein thrombosis; concurrent coumarin anticoagulants
Minor side effects: hot flashes; nausea; fatigue
Moderate side effects: vaginal discharge; fluid retention; menstrual irregularities
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Onset Time: 4–8 weeks
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Warfarin; Rifampin; Paroxetine
Age restrictions: Approved for adults.

Serious side effects

venous thromboembolism, requires immediate medical attention; endometrial cancer, requires immediate medical attention

Patient summary

formulated to alleviate estrogen-responsive tumour growth to support breast cancer remission and target cancer cells.

Mechanism of action

Competitively blocks estrogen receptors in breast tumour tissues, preventing cell transcription and tumour proliferation.

Pregnancy and breastfeeding

TGA Category D: Highly teratogenic. Do not use in pregnancy. Breastfeeding: Contraindicated.

Tamoxifen Tablets is a generic medicine sold under the name of its active ingredient, Tamoxifen, rather than under a brand.

The fulfilment partner confirms the offered manufacturer and product before supply.
Check the active ingredient, strength, form and pack shown at checkout before confirming an order.